Search

everythinglearnresearchcommunity

for

Search:↓

A new mutation in the STING protein causes a disease with lupus-like symptoms and responds well to a specific inhibitor treatment.

Tofacitinib may effectively treat skin symptoms in difficult cases of dermatomyositis.

Tofacitinib significantly improved symptoms in a patient with overlapping autoimmune disorders.

Telitacicept effectively improved hair regrowth in a woman with lupus and alopecia.

Upadacitinib improved multiple immune-related conditions in one patient.

The choice between belimumab and anifrolumab depends on the specific symptoms of the patient's lupus.

The choice between belimumab and anifrolumab for treating lupus depends on the patient's specific symptoms.

Telitacicept helped stabilize complement levels in a patient with lupus and thyroid cancer.

Ixekizumab helps improve life quality, physical ability, and work performance in patients with psoriatic arthritis who haven't used biologic drugs before.

COVID-19 infection rates were low in patients with immune diseases, regardless of their treatment type.

Biosimilars lower costs but don't significantly improve access.

Tranilast successfully treated a man's skin sarcoidosis when other treatments failed.

A man developed temporary hair loss after taking a cancer drug, which might indicate a better treatment response.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

Tofacitinib significantly improved hair loss and lesions in a patient with overlapping autoimmune disorders.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

Nemolizumab improved both severe atopic dermatitis and alopecia areata in one patient.

A JAK inhibitor improved both severe hair loss and chronic skin disease in one patient.

Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.

Tofacitinib helps improve skin conditions in people with Down syndrome, especially alopecia areata.

Trodelvy™ helped some patients with advanced breast cancer, but had side effects.

Anifrolumab may help improve symptoms in patients with overlapping autoimmune diseases.

A woman with severe angioedema improved significantly after treatment with rituximab.

A young woman had a rare skin reaction to a medication for her joint disease, and a combination therapy improved her condition.

BMS-470539 reduces skin fibrosis and inflammation.

Co-trimoxazole may help treat autoimmune diseases.

UTMD with diclofenac and Doxil® improves cancer treatment by boosting immune response and reducing tumor-supporting cells.

Intensive immunosuppression can reduce relapse rates in multiple sclerosis patients, despite some side effects.

SIG-1451 could be a promising new treatment for atopic dermatitis.